Screening for inhalational anthrax due to bioterrorism: Evaluating proposed screening protocols

Clinical Infectious Diseases

Volumn 39, Issue 12, 2004, Pages 1842-1847

  Howell, John M ^a   Mayer, Thom A ^a   Hanfling, Dan ^a   Morrison, Allan ^a   Druckenbrod, Glenn ^a   Murphy, Cecele ^a   Cates, Robert ^a   Pauze, Denis ^a  

^a INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL VIRULENCE; BIOLOGICAL WARFARE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC TEST; ENVIRONMENTAL EXPOSURE; EPIDEMIC; EPIDEMIOLOGICAL DATA; FEVER; HEALTH CARE COST; HUMAN; HUPERT SCREENING TEST; INTERMETHOD COMPARISON; MAYER SCREENING TEST; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING TEST; SYMPTOM; TACHYCARDIA;

ADULT; ANTHRAX; BIOLOGICAL WARFARE; BIOTERRORISM; DISEASE OUTBREAKS; DOXYCYCLINE; EARLY DIAGNOSIS; HUMANS; INHALATION; MASS SCREENING; RETROSPECTIVE STUDIES; VIRGINIA;

EID: 10644269348     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/426080     Document Type: Article

References (8)

1. Mayer TA, Morrison A, Bersoff-Matcha S, et al. Inhalational anthrax due to bioterrorism: would current centers for disease control and prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001? Clin Infect Dis 2003; 36: 1275-83.
2. Hupert N, Bearman GML, Mushlin AI, Callahan MA. Accuracy of screening for inhalational anthrax after a bioterrorist attack. Ann Intern Med 2003; 139:337-45.
3. Centers for Disease Control and Prevention. Notice to readers: considerations for distinguishing influenza-like illness from inhalational anthrax. MMWR Morb Mortal Wkly Rep 2001; 50:941-8.
4. 2002 drug topics red book. Montvale, NJ: Medical Economics, 2002.
5. Gerberding JL, Hughes JM, Koplan JP. Bioterrorism preparedness and response: clinicians and public health agencies as essential partners. JAMA 2002; 287:898-900.
6. Danzig R. Catastrophic bioterrorism: what is to be done? Washington, DC: Center for Technology and National Security Policy, National Defense University, 2003.
7. Lane HC, Fauci AS. Bioterrorism on the home front: a new challenge for American medicine. JAMA 2001; 286:2595-7.
8. Sox HC. A triage algorithm for inhalational anthrax. Ann Intern Med 2003; 139:379-81.